Skip to content
Open access · CC-BY via OpenAlex

Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy

Flávia Siqueira Cunha, Tânia A.S.S. Bachega, Elaine Maria Frade Costa, Vinícius Nahime Brito, Leonardo Azevedo Mobília Alvares, Valéria Costa‐Hong, Renata Gomes Sanches Verardino, Maria Helena Palma Sircili, Berenice Bilharinho Mendonca, Luiz Aparecido Bortolotto, Sorahia Domenice

Journal of the Endocrine Society · 2023 · ▲ 20 citations

Abstract

Context: The effects of androgen therapy on arterial function in transgender men (TM) are not fully understood, particularly concerning long-term androgen treatment. Objective: To evaluate arterial stiffness in TM receiving long-term gender-affirming hormone therapy by carotid-femoral pulse wave velocity (cf-PWV). Methods: A cross-sectional case-control study at the Gender Dysphoria Unit of the Division of Endocrinology, HC-FMUSP, Sao Paulo, Brazil. Thirty-three TM receiving intramuscular testosterone esters as regular treatment for an average time of 14 ± 8 years were compared with 111 healthy cisgender men and women controls matched for age and body mass index. Aortic stiffness was evaluated by cf-PWV measurements using Complior device post-testosterone therapy. The main outcome measure was aortic stiffness by cf-PWV as a cardiovascular risk marker in TM and control group. Results: = .02). The cf-PWV was significantly and positively correlated with age. Analysis using blood pressure as a covariate showed a significant relationship between TM systolic blood pressure (SBP) and cf-PWV in relation to cisgender women but not to cisgender men. Age, SBP, and diagnosis of hypertension were independently associated with cf-PWV in the TM group. Conclusion: The TM group on long-term treatment with testosterone had higher aging-related aortic stiffening than the control groups. These findings indicate that aortic stiffness might be accelerated in the TM group receiving gender-affirming hormone treatment, and suggest a potential deleterious effect of testosterone on arterial function. Preventive measures in TM individuals receiving testosterone treatment, who are at higher risk for cardiovascular events, are highly recommended.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1210/jendso/bvad040
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Cunha, F.S., Bachega, T.A., Costa, E.M.F., Brito, V.N., Alvares, L.A.M., Costa‐Hong, V., Verardino, R.G.S., Sircili, M.H.P., Mendonca, B.B., Bortolotto, L.A., &amp; Domenice, S. (2023). Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy. <em>Journal of the Endocrine Society</em>. https://doi.org/10.1210/jendso/bvad040
Vancouver
Cunha FS, Bachega TA, Costa EMF, Brito VN, Alvares LAM, Costa‐Hong V, et al. Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy. Journal of the Endocrine Society. 2023. doi:10.1210/jendso/bvad040.
BibTeX
@article{flvia2023Arteri, title = {Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy}, author = {Flávia Siqueira Cunha and Tânia A.S.S. Bachega and Elaine Maria Frade Costa and Vinícius Nahime Brito and Leonardo Azevedo Mobília Alvares and Valéria Costa‐Hong and Renata Gomes Sanches Verardino and Maria Helena Palma Sircili and Berenice Bilharinho Mendonca and Luiz Aparecido Bortolotto and Sorahia Domenice}, journal = {Journal of the Endocrine Society}, year = {2023}, doi = {10.1210/jendso/bvad040}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings